Our previous studies have demonstrated that DKK3 expression is observed in certain cancers, such as OSCC and esophageal squamous cell carcinoma, and DKK3 increases tumor malignancy through Akt activation in such cancers, while its expression is lost in many kinds of malignancies. This evidence concerns the gene AKT1 and cancer.